Healthcare
Wednesday, February 1, 2017
BRIEF-Nanobiotix expects first European market authorization for NBTXR3 in 2017
* Announced on Tuesday that first European market
authorization for NBTXR3 is expected in 2017
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment